Schreiner MediPharm introduces late stage customization for functional labels

  • Schreiner MediPharm

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has launched a process center for late stage customization of functional labels.  Allowing for greater flexibility and supporting highly variable packaging needs, the new service addresses the demands of a more agile and responsive pharmaceutical industry supply chain that is increasingly driven by segmentation initiatives.

For Schreiner MediPharm, providing dedicated service for late stage customization of its sophisticated functional labels helps ensure optimal process flow while still guaranteeing that the pharmaceutical industry’s exacting quality requirements are met.

In recent years, the pharmaceutical industry has been challenged by ever-changing market conditions and a significant uptick in segmentation needs. Factors such as country-specific regulations, different languages and special packaging formats require high flexibility and adjustments with short lead times. Pharmaceutical products targeting more specialized medical needs – including orphan drugs – and growing cost pressures also play important roles.

For customers, Schreiner MediPharm’s streamlined process allows for expedited label specialization. Initially, the labels are pre-produced in large quantities with all required functional features – including, for example, die-cut hangers, detachable documentation parts and integrated security features.  Printed with standard text, the labels are stored as semi-finished products in Schreiner MediPharm’s warehouse.  On demand, the pre-manufactured labels are customized using digital printing and delivered within a few days, making segmentation requirements such as small volumes and varying demand far less challenging for drug manufacturers.

An expert team of late stage customization specialists provides comprehensive consulting support on a case by case basis. Specific workflows and shared processes are developed in joint workshops with the respective customers – a transparent, partnership-based approach that helps ensure on-demand product expedition without sacrificing quality.

“Pharmaceutical customers benefit from our late stage label customization through short lead times, fast delivery and high flexibility,” said Gene Dul, President of Schreiner MediPharm U.S. “Furthermore, the customer saves internal costs: There are no minimum order quantities, warehousing expenses are minimized and wasting of printed labels due to text revisions is eliminated.”

See also

Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks.

Schreiner MediPharm develops smart blister pack for clinical trial

Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.

Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility

Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.

  • Elias Bittan
  • Product Info
  • English
  • Created 03 May 2016
  • Modified 09 May 2016
  • Hits 1016